AAAAAA

   
Results: 1-7 |
Results: 7
GEMFIBROZIL TREATMENT INCREASES LOW-DENSITY-LIPOPROTEIN PARTICLE-SIZEIN TYPE-2 DIABETES-MELLITUS BUT DOES NOT ALTER IN-VITRO OXIDIZABILITY
Authors: ONEAL DN OBRIEN RC TIMMINS KL GRIEVE GD LAU KP NICHOLSON GC KOTOWICZ MA BEST JD
Citation: Dn. Oneal et al., GEMFIBROZIL TREATMENT INCREASES LOW-DENSITY-LIPOPROTEIN PARTICLE-SIZEIN TYPE-2 DIABETES-MELLITUS BUT DOES NOT ALTER IN-VITRO OXIDIZABILITY, Diabetic medicine, 15(10), 1998, pp. 870-877
LIPID-LEVELS AND PERIPHERAL VASCULAR-DISEASE IN DIABETIC AND NONDIABETIC SUBJECTS
Authors: ONEAL DN LEWICKI J ANSARI MZ MATTHEWS PG BEST JD
Citation: Dn. Oneal et al., LIPID-LEVELS AND PERIPHERAL VASCULAR-DISEASE IN DIABETIC AND NONDIABETIC SUBJECTS, Atherosclerosis, 136(1), 1998, pp. 1-8
LOW-DENSITY-LIPOPROTEIN SIZE, HIGH-DENSITY-LIPOPROTEIN CONCENTRATION,AND ENDOTHELIAL DYSFUNCTION IN NON-INSULIN-DEPENDENT DIABETES
Authors: OBRIEN SF WATTS GF PLAYFORD DA BURKE V ONEAL DN BEST JD
Citation: Sf. Obrien et al., LOW-DENSITY-LIPOPROTEIN SIZE, HIGH-DENSITY-LIPOPROTEIN CONCENTRATION,AND ENDOTHELIAL DYSFUNCTION IN NON-INSULIN-DEPENDENT DIABETES, Diabetic medicine, 14(11), 1997, pp. 974-978
LIPID RISK-FACTORS FOR PERIPHERAL VASCULAR-DISEASE IN PATIENTS WITH TYPE-2 DIABETES
Authors: BEST JD ONEAL DN
Citation: Jd. Best et Dn. Oneal, LIPID RISK-FACTORS FOR PERIPHERAL VASCULAR-DISEASE IN PATIENTS WITH TYPE-2 DIABETES, Atherosclerosis, 134(1-2), 1997, pp. 306-306
ATORVASTATIN AND SIMVASTATIN REDUCE ELEVATED CHOLESTEROL IN NON-INSULIN-DEPENDENT DIABETES
Authors: BEST JD NICHOLSON GC ONEAL DN KOTOWICZ MA TEBBUTT NC CHAN KW SANDERS KM
Citation: Jd. Best et al., ATORVASTATIN AND SIMVASTATIN REDUCE ELEVATED CHOLESTEROL IN NON-INSULIN-DEPENDENT DIABETES, Diabetes, nutrition & metabolism, 9(2), 1996, pp. 74-80
THE EFFECT OF 3 MONTHS OF RECOMBINANT HUMAN GROWTH-HORMONE (GH) THERAPY ON INSULIN AND GLUCOSE-MEDIATED GLUCOSE DISPOSAL AND INSULIN-SECRETION IN GH-DEFICIENT ADULTS - A MINIMAL MODEL ANALYSIS
Authors: ONEAL DN KALFAS A DUNNING PL CHRISTOPHER MJ SAWYER SD WARD GM ALFORD FP
Citation: Dn. Oneal et al., THE EFFECT OF 3 MONTHS OF RECOMBINANT HUMAN GROWTH-HORMONE (GH) THERAPY ON INSULIN AND GLUCOSE-MEDIATED GLUCOSE DISPOSAL AND INSULIN-SECRETION IN GH-DEFICIENT ADULTS - A MINIMAL MODEL ANALYSIS, The Journal of clinical endocrinology and metabolism, 79(4), 1994, pp. 975-983
THE EFFECT OF 3 MONTHS OF RECOMBINANT HUMAN GROWTH-HORMONE (GH) THERAPY ON INSULIN AND GLUCOSE-MEDIATED GLUCOSE DISPOSAL AND INSULIN-SECRETION IN GH-DEFICIENT ADULTS - A MINIMAL MODEL ANALYSIS
Authors: ONEAL DN KALFAS A DUNNING PL CHRISTOPHER MJ SAWYER SD WARD GM ALFORD FP
Citation: Dn. Oneal et al., THE EFFECT OF 3 MONTHS OF RECOMBINANT HUMAN GROWTH-HORMONE (GH) THERAPY ON INSULIN AND GLUCOSE-MEDIATED GLUCOSE DISPOSAL AND INSULIN-SECRETION IN GH-DEFICIENT ADULTS - A MINIMAL MODEL ANALYSIS, The Journal of clinical endocrinology and metabolism, 79(4), 1994, pp. 975-983
Risultati: 1-7 |